首页> 外文期刊>Nature Communications >The nuclear hormone receptor PPARγ counteractsvascular calcification by inhibiting Wnt5a signallingin vascular smooth muscle cells
【24h】

The nuclear hormone receptor PPARγ counteractsvascular calcification by inhibiting Wnt5a signallingin vascular smooth muscle cells

机译:核激素受体PPARγ通过抑制血管平滑肌细胞中的Wnt5a信号传导来抵消血管钙化

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular calcification is a hallmark of advanced atherosclerosis. Here we show that deletionof the nuclear receptor PPARγ in vascular smooth muscle cells of low density lipoproteinreceptor (LDLr)-deficient mice fed an atherogenic diet high in cholesterol, accelerates vascularcalcification with chondrogenic metaplasia within the lesions. Vascular calcification in theabsence of PPARγ requires expression of the transmembrane receptor LDLr-related protein-1 in vascular smooth muscle cells. LDLr-related protein-1 promotes a previously unknownWnt5a-dependent prochondrogenic pathway. We show that PPARγ protects against vascularcalcification by inducing the expression of secreted frizzled-related protein-2, which functionsas a Wnt5a antagonist. Targeting this signalling pathway may have clinical implications in thecontext of common complications of atherosclerosis, including coronary artery calcificationand valvular sclerosis.
机译:血管钙化是晚期动脉粥样硬化的标志。在这里,我们表明,低密度脂蛋白受体(LDLr)缺陷小鼠的血管平滑肌细胞中的核受体PPARγ的缺失,饲喂高胆固醇的致动脉粥样化饮食,可促进病变内软骨形成的化生。 PPARγ缺失时的血管钙化需要在血管平滑肌细胞中表达跨膜受体LDLr相关蛋白-1。 LDLr相关蛋白1促进以前未知的Wnt5a依赖的软骨形成途径。我们表明,PPARγ通过诱导分泌的卷曲相关蛋白2的表达来防止血管钙化,该蛋白起Wnt5a拮抗剂的作用。在动脉粥样硬化的常见并发症(包括冠状动脉钙化和瓣膜硬化)的背景下,靶向该信号通路可能具有临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号